These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7313576)

  • 1. Interstitial fluid concentrations of cefsulodin, azlocillin and carbenicillin.
    Landau Z; Halkin H; Rubinstein E
    Scand J Infect Dis; 1981; 13(3):227-32. PubMed ID: 7313576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tissue penetration, as measured by a blister technique, and pharmacokinetics of cefsulodin compared with carbenicillin and ticarcillin.
    Findlay CD; Wise R; Allcock JE; Durham SR
    J Antimicrob Chemother; 1981 Jun; 7(6):637-42. PubMed ID: 7251531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of Pseudomonas aeruginosa to azlocillin, ticarcillin and cefsulodin.
    Elliott TS; Greenwood D
    J Med Microbiol; 1983 Aug; 16(3):351-62. PubMed ID: 6410071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriological studies with cefsulodin (CGP 7174/E), the first antipseudomonal cephalosporin.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):563-7. PubMed ID: 115832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
    Perea EJ; Palomares JC; García-Iglesias MC
    Chemotherapy; 1980; 26(4):282-8. PubMed ID: 6248300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
    Labia R; Morand A; Ben Yaghlane H
    Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D; Eley A
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefsulodin pharmacokinetics and otitis media.
    Federspil P; Schätzle W; Tiesler E
    Arch Otorhinolaryngol; 1982; 236(2):123-30. PubMed ID: 7150078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Monteil H; Peladan F; Zinsius M
    Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
    Henderson JL; Polk RE; Kline BJ
    Am J Hosp Pharm; 1981 Aug; 38(8):1167-70. PubMed ID: 6455916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cephalosporin and carbenicillin penetration into the tissues of rats with aseptic inflammation].
    Agapitova IV; Bobrov VI
    Antibiotiki; 1984 Jun; 29(6):427-30. PubMed ID: 6476804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
    Duval J; Soussy CJ
    Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)].
    Segura C; Foz A; Fuster C; Tirado M; Roy C
    Med Clin (Barc); 1981 Jun; 77(2):50-5. PubMed ID: 6798336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.